Genmab Wraps Up Leveraged Finance’s Biggest M&A Deal Since April

{# Share Buttons Partial Variables: share_title — text to pre-fill in share dialogs share_url — canonical URL to share (use request.build_absolute_uri in parent) #}

Market Intelligence Analysis

AI-Powered
Why This Matters

Genmab A/S completed a $4.5 billion acquisition funding deal, the largest in the US leveraged finance market since April, using junk bonds and a leveraged loan.

Market Impact

Market impact analysis based on bullish sentiment with 77% confidence.

Sentiment
Bullish
AI Confidence
77%

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

Genmab A/S completed the US leveraged finance market’s largest acquisition funding since April, raising $4.5 billion through junk bonds and a leveraged loan.

Continue Reading
Full article on Bloomberg
Read Full Article
Original article published by Bloomberg on November 19, 2025.
Analysis and insights provided by AnalystMarkets AI.